Eisai Sues FDA To Reclaim Lost Exclusivity For 2 Drugs

By Jeff Overley (August 8, 2014, 6:34 PM EDT) -- Eisai Inc. on Friday sued the U.S. Food and Drug Administration in D.C. federal court for refusing to adjust the approval dates of two prescription drugs to reflect the actual dates on which they were allowed to be sold, accusing regulators of reducing its market exclusivity by arbitrarily declining to be flexible....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!